A detailed history of Pdt Partners, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Pdt Partners, LLC holds 44,810 shares of EXAS stock, worth $2.26 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
44,810
Holding current value
$2.26 Million
% of portfolio
0.3%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.43 - $70.83 $1.9 Million - $3.17 Million
44,810 New
44,810 $3.05 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $774,333 - $1.16 Million
11,743 Added 27.11%
55,060 $3.76 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $2.72 Million - $4.12 Million
43,317 New
43,317 $4.07 Million
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $717,750 - $996,732
-9,900 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $893,376 - $1.23 Million
9,900 New
9,900 $945,000
Q4 2020

Feb 16, 2021

SELL
$99.61 - $142.12 $360,588 - $514,474
-3,620 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $101,140 - $141,487
-1,387 Reduced 27.7%
3,620 $369,000
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $279,140 - $464,399
5,007 New
5,007 $435,000
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $1.3 Million - $3.58 Million
-34,294 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $3.82 Million - $4.91 Million
-49,206 Reduced 58.93%
34,294 $3.17 Million
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $3.74 Million - $4.93 Million
-41,800 Reduced 33.36%
83,500 $9.86 Million
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $1.89 Million - $2.94 Million
-30,500 Reduced 19.58%
125,300 $10.9 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $56 - $82
-1 Reduced -0.0%
155,800 $9.83 Million
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $2 Million - $3.34 Million
41,501 Added 36.31%
155,801 $12.3 Million
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $4.33 Million - $8 Million
114,300 New
114,300 $6.83 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.93B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.